https://www.selleckchem.com/pr....oducts/valemetostat-
The age of patients undergoing implantation increased annually from an average of 26.6-57.2 years (p less then 0.001). The implantation rates from 2003 to 2016, per 100,000 enrollees, increased from 1.64 to 6.82 for patients 60-79 years of age, and 0 to 11.57 for patients greater than 80 years of age (p less then 0.001). No significant differences in 30-day complication rates were found between patients when grouped by age in decades, except for device related problems, which was significantly higher in younger patients
Like
Comment
Share
